| 1. |
- Areàn, Patricia A, et al.
(författare)
-
Mobile technology for mental health assessment.
- 2016
-
Ingår i: Dialogues in Clinical Neuroscience. - Neuilly sur Seine, France : Les Laboratoires Servier. - 1294-8322 .- 1958-5969. ; 18:2, s. 163-169
-
Tidskriftsartikel (refereegranskat)abstract
- Assessment and outcome monitoring are critical for the effective detection and treatment of mental illness. Traditional methods of capturing social, functional, and behavioral data are limited to the information that patients report back to their health care provider at selected points in time. As a result, these data are not accurate accounts of day-to-day functioning, as they are often influenced by biases in self-report. Mobile technology (mobile applications on smartphones, activity bracelets) has the potential to overcome such problems with traditional assessment and provide information about patient symptoms, behavior, and functioning in real time. Although the use of sensors and apps are widespread, several questions remain in the field regarding the reliability of off-the-shelf apps and sensors, use of these tools by consumers, and provider use of these data in clinical decision-making.
|
|
| 2. |
- Evers, Kathinka, 1960-
(författare)
-
Neurotechnological assessment of consciousness disorders : five ethical imperatives
- 2016
-
Ingår i: Dialogues in Clinical Neuroscience. - 1294-8322 .- 1958-5969. ; 18:2, s. 155-162
-
Tidskriftsartikel (refereegranskat)abstract
- Disorders of consciousness (DOCs) cause great human suffering and material costs for society. Understanding of these disorders has advanced remarkably in recent years, but uncertainty remains with respect to the diagnostic criteria and standards of care. One of the most serious problems concerns misdiagnoses, their impact on medical decision-making, and on patients' well-being. Recent studies use neurotechnology to assess residual consciousness in DOC patients that traditional behavioral diagnostic criteria are unable to detect. The results show an urgent need to strengthen the development of new diagnostic tools and more refined diagnostic criteria. If residual consciousness may be inferred from robust and reproducible results from neurotechnological communication with DOC patients, this also raises ethical challenges. With reference to the moral notions of beneficence and fundamental rights, five ethical imperatives are here suggested in terms of diagnosis, communication, interpretation of subjective states, adaptation of living conditions, and care.
|
|
| 3. |
- Qiu, C, et al.
(författare)
-
Epidemiology of Alzheimer's disease : occurrence, determinants, and strategies toward intervention
- 2009
-
Ingår i: Dialogues in Clinical Neuroscience. - : Les Laboratoires Servier. - 1294-8322 .- 1958-5969. ; 11:2, s. 111-128
-
Tidskriftsartikel (refereegranskat)abstract
- More than 25 million people in the world today are affected by dementia, most suffering from Alzheimer's disease. In both developed and developing nations, Alzheimer's disease has had tremendous impact on the affected individuals, caregivers, and society. The etiological factors, other than older age and genetic susceptibility, remain to be determined. Nevertheless, increasing evidence strongly points to the potential risk roles of vascular risk factors and disorders (eg, cigarette smoking, midlife high blood pressure and obesity, diabetes, and cerebrovascular lesions) and the possible beneficial roles of psychosocial factors (eg, high education, active social engagement, physical exercise, and mentally stimulating activity) in the pathogenetic process and clinical manifestation of the dementing disorders. The long-term multidomain interventions toward the optimal control of multiple vascular risk factors and the maintenance of socially integrated lifestyles and mentally stimulating activities are expected to reduce the risk or postpone the clinical onset of dementia, including Alzheimer's disease.
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
- Carlsson, Arvid, 1923, et al.
(författare)
-
A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.
- 2006
-
Ingår i: Dialogues in clinical neuroscience. - 1294-8322. ; 8:1, s. 137-42
-
Tidskriftsartikel (refereegranskat)abstract
- In contrast to the conventional view of dopamine involvement in schizophrenia, which posits hyperactive dopaminergic transmission, we propose that for unknown developmental and/or biochemical reasons, a primary defect occurs in efficient, tight dopaminergic synaptic transmission, triggering feedback activation and receptor upregulation, and resulting in the well-characterized increase in dopaminergic tone. This hypothesis is driven by suggestive evidence for subpopulations of dopamine D2 receptors delivering contrasting forms of dopaminergic transmission: synaptic receptors, responsible for basic dopaminergic function and subject to effective feedback control, and poorly controlled extrasynaptic receptors partly responsible for the positive symptoms of psychosis. Since the primary defect is dopamine deficiency, we term this theory the dopaminergic deficit hypothesis of schizophrenia. It is currently informing clinical studies with novel partial dopamine antagonists (dopamine stabilizers) such as ACR16, which preferentially target extrasynaptic receptors while leaving synaptic transmission and basic dopamine function intact.
|
|
